Dwight Koeberl MD

PubMed

• Genetic analysis and multimodal imaging confirm m.12148 T > C mitochondrial variant pathogenicity leading to multisystem dysfunction.
  Kinsley Belle, Alexander Kreymerman, Jill L Young, Nirmal Vadgama, Marco H Ji
  Molecular Genetics and Metabolism. 2025-03-01
• 1 citations
  The attenuated hepatic clearance of propionate increases cardiac oxidative stress in propionic acidemia.
  You Wang, Suhong Zhu, Wentao He, Hannah Marchuk, Eva Richard
  Basic Research in Cardiology. 2024-12-01
• Staying on target in gene and cell therapy.
  Rory Bricker-Anthony, Dwight D Koeberl, Gerald S Lipshutz, Fabiana Perna
  Molecular Therapy. 2024-09-04

Journal Articles

• Beta2 agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine pompe disease  
  Koeberl DD, Li S, Dai J, Thurberg BL, Bali D, and Kishnani PS, Mol Genet Metab, 1/1/2012
• Immunodominant liver-specific expression suppresses transgene-directed immune responses in murine Pompe disease  
  Zhang P, Sun B, Osada T, Rodriguiz R, Yang XY, Luo X, Kemper AR, Clay TM, Koeberl DD, Hum Gene Ther, 1/1/2012
• Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus- mediated gene therapy  
  Sun,B, Young SP, Li P, Di C, Brown T, Salva MZ, Li S, Bird A, Yan Z, Auten R, Hauschka SD, and Koeberl DD, Mol Ther, 1/1/2008
• Enhanced response to enzyme replacement therapy in Pompe disease following the induction of immune tolerance  
  Sun B, Bird A, Young SP, Kishnani PS, Chen YT, and Koeberl DD, Am J Hum Genet, 1/1/2007
• Adjunctive Beta2-agonists reverse neuromuscular involvement in murine Pompe disease  
  Li S, Sun B, Nilsson MI, Bird A, Tarnopolsky MA, Thurberg BL, Bali D, Koeberl DD, FASEB
• Join now to see all